Doctors rely on our expertise to deliver tailored medicine, says compounder by Steve Jones November 9, 2023November 9, 2023 One of Australia’s largest compounders of medicinal cannabis has insisted bespoke formulations have a vital role […]
Clinic says ‘significant’ volumes of non-GMP product remain in market by Steve Jones November 8, 2023November 8, 2023
Decriminalise home-grown cannabis but full legal market ‘worries the hell out of me’, says Cann Group boss by Steve Jones November 7, 2023November 7, 2023
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
‘There are a lot of sad stories’: Doctor tells of impact on children following TGA prescribing rule change by Steve Jones October 31, 2023November 2, 2023
Australian authorities urged to join global effort to answer cannabis impairment question by Martin Lane October 30, 2023October 30, 2023
Cronos vows to block former director’s return to the Vitura board by Martin Lane October 30, 2023October 31, 2023
Regulators on alert as rise of flower compounding sparks concern by Steve Jones October 26, 2023October 26, 2023
Vitura acquires digital health platform Doctors on Demand for A$25m by Steve Jones October 19, 2023October 19, 2023
Releaf Group targets ASX listing and plots growth of lifestyle division by Steve Jones October 19, 2023October 19, 2023
